VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,472 | -27.8% | 5,553 | +5.7% | 0.00% | -25.0% |
| Q2 2023 | $85,167 | +496.8% | 5,254 | +10.4% | 0.00% | +300.0% |
| Q1 2022 | $14,271 | -79.7% | 4,757 | -68.9% | 0.00% | 0.0% |
| Q4 2021 | $70,375 | -38.0% | 15,299 | -15.4% | 0.00% | -50.0% |
| Q3 2021 | $113,536 | +98.3% | 18,079 | +89.1% | 0.00% | +100.0% |
| Q2 2021 | $57,258 | -55.7% | 9,559 | -53.3% | 0.00% | -50.0% |
| Q1 2021 | $129,340 | +152.6% | 20,449 | +124.8% | 0.00% | +100.0% |
| Q4 2020 | $51,205 | -38.3% | 9,095 | -36.3% | 0.00% | 0.0% |
| Q3 2020 | $83,040 | -46.9% | 14,268 | -34.2% | 0.00% | -66.7% |
| Q2 2020 | $156,291 | +53.5% | 21,677 | -0.4% | 0.00% | +50.0% |
| Q1 2020 | $101,823 | -38.5% | 21,757 | +5.4% | 0.00% | -33.3% |
| Q4 2019 | $165,605 | +13.8% | 20,649 | -2.4% | 0.00% | +50.0% |
| Q3 2019 | $145,553 | -17.1% | 21,156 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $175,595 | -12.2% | 21,156 | +5.1% | 0.00% | -25.0% |
| Q1 2019 | $200,072 | +19.3% | 20,128 | -8.2% | 0.00% | +33.3% |
| Q4 2018 | $167,703 | -37.2% | 21,922 | +43.1% | 0.00% | -40.0% |
| Q3 2018 | $266,927 | -99.8% | 15,323 | 0.0% | 0.01% | +150.0% |
| Q2 2018 | $145,415,000 | – | 15,323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |